已核实 DOI PubMed 相关产品: 1

Oxidation Responsive PEGylated Polyamino Acid Bearing Thioether Pendants for Enhanced Anticancer Drug Delivery

Journal 2023 · IF 4.6 · 23(3): 2200498 · 发表于 2023 年 1 月 6 日
作者: Yitao Sun,Yu Zhang,Xin Guo,Yanping Wang,Pan He,Chunsheng Xiao
阅读全文 在 PubMed 查看

摘要

Reactive oxygen species (ROS) in biological tissues are in a state of dynamic balance. However, many diseases such as cancer and inflammation, are accompanied by a long-term increase in ROS. This situation inspires researchers to use ROS-sensitive nanocarriers for a site-specific release of cargo in pathological areas. Polyamino acid materials with good biodegradability, biocompatibility, and regular secondary structure are widely used in the biomedical field. Herein, a new oxidation responsive PEGylated polyamino acid is synthesised for anticancer drug delivery by ring-opening polymerisation of N -carboxyanhydrides bearing thioether pendants. The obtained block copolymer mPEG- b -PMLG self-assembles into spherical nanoparticles (NPs) in water with diameter ≈68.3 nm. NMR measurement demonstrated that the hydrophobic thioether pendants in the NPs can be selectively oxidised to hydrophilic sulfoxide groups by H 2 O 2 , which will lead to the disassociation of NPs. In vitro drug release results indicated that the encapsulated Nile red is selectively released in the trigger of 10 mM H 2 O 2 in PBS. Finally, anticancer drug doxorubicin (DOX) is encapsulated to the NPs, and the obtained NPs/DOX exhibits an improved antitumor efficacy in 4T1 tumour-bearing mice and lower cardiotoxicity than free DOX. These results indicates that the mPEG- b -PMLG NPs are promising for anticancer drug delivery.

本研究中使用的阿拉丁产品

1 款产品在本文中被引用